Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA253027, R00CA259329)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL148667)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
First Online: 15 December 2023
Competing interests
: W.W. is a co-founder and consultant for ReKindle Therapeutics.